Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, RCT Protocol for a treatment study, from an institute at Zurich University. They might possibly be a capable partner for other studies and trials. For example, they run an MS registry. I wonder if they are working with any patient organisations to promote the study.